HILT and US Therapies in Adhesive Capsulitis
Adhesive Capsulitis of Shoulder
About this trial
This is an interventional treatment trial for Adhesive Capsulitis of Shoulder focused on measuring Frozen Shoulder, Ultrasound, High-Intensity Laser Therapy
Eligibility Criteria
Inclusion Criteria:
- Clinically diagnosed with primary (idiopathic) AC,
- Pain and movement restriction in his or her shoulder for at least 3 months,
- Restriction of passive external rotation in the involved shoulder restricted with less than 50% of the contralateral shoulder,
- Normal radiography findings
Exclusion Criteria:
- Both shoulders were involved,
- Other shoulder pathologies (glenohumeral osteoarthritis, calcific tendinitis, rotator cuff tear, etc.),
- Cervical radiculopathy,
- Brachial plexus lesion,
- Neuromuscular disorders,
- Inflammatory rheumatic disorders,
- Malignancy,
- Acute trauma,
- Patients who had fracture affecting the involved shoulder joint, patients who underwent a surgical intervention, patients who underwent intraarticular injection for the involved shoulder within the last 6 months,
- Patients who received physical therapy for the glenohumeral joint within the last 1 year, and
- Photoallergy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Ultrasound Therapy
High-Intensity Laser Therapy
The patients in group 1 received therapeutic US with BTL-4710 ultrasound device. The therapeutic US was administered at the frequency of 3 megahertz, intensity of 1.5 w/cm2 and an area of 25 cm2 for 5 minutes in the continue mode. The procedure of therapeutic US was performed by a physiotherapist experienced in using the device for 15 sessions in total 5 times a week for 3 weeks.
The patients in group 2 received HILT with BTL-6000 high-intensity laser device. The therapy consisted of 2 stages in each session. The first stage was performed in analgesic mode for analgesic effect at the frequency of 25 Hz, in the wavelength of 1064 nm, the power of 8 watt, the dose of 12 j/cm2, the area of 25 cm2, and 300 j in total for 2 minutes and 30 seconds. The second stage was performed in bio-stimulating mode for biostimulation effect in the wavelength of 1064 nm, the power of 7 watt, the dose of 100 j/cm2, the area of 25 cm2, and 2500 j in total for 5 minutes and 57 seconds. The total length of administration was approximately 8.5 minutes for each stage. The procedure of the therapy was performed by a physiotherapist experienced in using the device for 9 sessions in total 3 times a week for 3 weeks.